tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Virax Biolabs Group Ltd

VRAX
Add to Watchlist
2.500USD
+0.190+8.23%
Close 09-22 16:00（ET）
2.00MMarket Cap
LossP/E TTM

Virax Biolabs Group Ltd

2.500
+0.190+8.23%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

VRAX Financials

See Virax Biolabs Group Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
2.00M
Dividend TTM
0.00
P/E TTM
-1.57
EPS TTM
-1.62
Revenue
12.42K
Net Profit
-6.06M
ROE
-109.58%
ROA
-101.88%

Virax Biolabs Group Ltd Earnings Date

Latest Release
Jul 6, 2026
EPS / Forecast
-12.64/--
Revenue / Forecast
12.42K/--

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026H2
FY2025H2
FY2025H1
FY2024H2
FY2024H1
FY2023H2
FY2023H1
FY2022Q4
FY2022Q2
Financial Indicators
EPS
----
---0.76
---0.89
----
----
----
----
---1.50
----
Revenue
684.83%10.81K
----
-93.53%4.95K
2753.23%79.92K
1228.13%76.50K
--2.80K
--5.76K
----
----
Net Profit
18.76%-2.68M
----
5.27%-2.76M
4.73%-3.82M
-101.55%-2.91M
---4.01M
---1.44M
----
----
Net Margin
----
---240251.67%
---55654.43%
----
----
----
----
----
----
Gross Margin
----
---3381.20%
---130.71%
----
----
----
----
----
----
Debt to assets ratio
----
--5.87%
--6.39%
----
----
----
----
----
----
Income Statement
Revenue
684.83%10.81K
----
-93.53%4.95K
2753.23%79.92K
1228.13%76.50K
--2.80K
--5.76K
----
----
Operating profit
-16.15%-3.81M
----
-6.38%-2.88M
20.79%-3.40M
-87.86%-2.71M
---4.29M
---1.44M
----
----
Net Profit
18.76%-2.68M
----
5.27%-2.76M
4.73%-3.82M
-101.55%-2.91M
---4.01M
---1.44M
----
----
Balance Sheet
Current assets
39.54%6.83M
11.72%4.89M
34.54%8.03M
-54.53%4.38M
12.69%5.97M
--9.63M
--5.30M
--48.71K
--43.03K
Total current liabilities
1.76%685.02K
298.70%673.21K
-11.82%693.97K
-81.41%168.85K
-31.11%787.02K
--908.40K
--1.14M
--1.25M
--1.05M
Total assets
29.53%8.32M
17.19%6.43M
34.41%9.44M
-44.11%5.48M
32.58%7.03M
--9.81M
--5.30M
--48.71K
--43.03K
Total liabilities
2.60%989.83K
179.48%964.75K
11.64%1.03M
-62.00%345.19K
-19.56%919.05K
--908.40K
--1.14M
--1.25M
--1.05M
Total equity
34.29%7.33M
6.29%5.46M
37.84%8.42M
-42.29%5.14M
46.92%6.11M
--8.90M
--4.16M
---1.20M
---1.00M
Cash Flow Statement
Net operating income
29.62%-1.86M
----
46.62%-1.92M
-48.11%-2.79M
-56.50%-3.59M
---1.88M
---2.30M
----
----
Net investment
67.88%-114.33K
----
64.98%-248.00K
-155.75%-456.27K
---708.18K
---178.40K
----
----
----
Net financing
9120.24%5.07M
----
10099.64%5.86M
-74.77%1.73M
-99.16%57.49K
--6.84M
--6.84M
----
----

FAQs

What is the total revenue of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its total revenue reached 12.42K, with a year-on-year change of 6.33K.

What are the current assets of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its current assets were 6.83M, with a year-on-year change of 39.54.

What are the total assets of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its total assets of Virax Biolabs Group Ltd were 8.32M, with a year-on-year change of 29.53.

What are the total liabilities of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its total liabilities of Virax Biolabs Group Ltd were 989.83K, with a year-on-year change of 2.60.

What is the total equity of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its total equity of Virax Biolabs Group Ltd was 7.33M, with a year-on-year change of 34.29.

What is the net operating income of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its net operating income of Virax Biolabs Group Ltd was -6.40M, with a year-on-year change of -3.84.

What is the net investment of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its net investment of Virax Biolabs Group Ltd was -255.83K, with a year-on-year change of 57.64.

What is the net financing of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its net financing of Virax Biolabs Group Ltd was 7.09M, with a year-on-year change of 22.05.

What is the Earnings Per Share (EPS) of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its Earnings Per Share (EPS) was -12.64, with a year-on-year change of -677.64.

What is the net income of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its net income was -5.02M, with a year-on-year change of 17.12.

What is the net margin of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its net profit margin was -40507.00, with a year-on-year change of 57.73.

What is the gross margin of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its gross margin was 61.90, with a year-on-year change of 107.38.

What is the debt-to-asset ratio of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its debt-to-asset ratio was 4.98, with a year-on-year change of -15.14.

What is the Return on Equity (ROE) of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its Return on Equity (ROE) was -75.70, with a year-on-year change of 30.92.

What is the Return on Assets (ROA) of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its Return on Assets (ROA) was -68.23, with a year-on-year change of 33.03.

What is the operating profit of Virax Biolabs Group Ltd?

According to Virax Biolabs Group Ltd's FY2026 earnings report, its operating profit was -6.40M, with a year-on-year change of -3.84.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy